US Expanded Access Program for Magrolimab in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Name: US Expanded Access Program for Magrolimab in Patients With Relapsed or Refractory Acute Myeloid Leukemia
License: Public Domain

Gilead Sciences

ClinicalTrials.gov · Datasets · License: Public Domain

relapsed/refractory acute myeloid leukemia, expanded access

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 825582
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.